. . " * 4 L/kg"@en . . . . . . . . . "19-Norethisterone"@en . . . . "19-Nor-17alpha-ethynyltestosterone"@en . . . "Progestins diffuse freely into target cells and bind to the progesterone receptor. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH surge."@en . . . . "17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one"@en . . . . . "Norlutin"@en . . . "Noriday"@en . . "17alpha-Ethynyl-17-hydroxy-4-estren-3-one"@en . . . . . . . . . . . "Camila"@en . . . . . . "8.51 \u00B1 2.19 (when a single dose is given to healthy women) "@en . . "17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one"@en . . . . . . . . . . . . . . . . "Mini-PE"@en . . . "19-Nor-17-alpha-ethynyltestosterone"@en . "19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one"@en . . "4-Estren-17alpha-ethynyl-17beta-ol-3-one"@en . . "Norethindrone"@en . . . . . . . "17alpha-Ethinyl-19-nortestosterone"@en . . . . . . . . . . . . "Noretisterona"@en . . . . "Utovlan"@en . . . . . . "17\u03B1-ethinyl-19-nortestosterone"@en . . . . . "17alpha-Ethynyl-4-estren-17-ol-3-one"@en . . . . "Take without regard to meals."@en . . . . "Norethindrone acetate is indicated for the treatment of secondary amenorrhea, endometriosis, and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer."@en . . "Primolut-N"@en . . "17-alpha-Ethynyl-4-estren-17-ol-3-one"@en . "17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one"@en . . "Micronovum"@en . . "A synthetic progestational hormone with actions similar to those of progesterone but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception. [PubChem]"@en . . "17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one"@en . "19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one"@en . . . . "Norluten"@en . . . "17-alpha-Ethynyl-17-hydroxy-4-estren-3-one"@en . . "17alpha-Ethynyl-19-nortestosterone"@en . . . . . . . . "approved"@en . "# FDA label "@en . "Norethindrone is excreted in both urine and feces, primarily as metabolites."@en . "19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one"@en . "19-nor-17\u03B1-ethynyltestosterone"@en . . "Norethisterone"@en . . "Humans and other mammals"@en . "19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one"@en . " "@en . "Norethisteron"@en . "17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one"@en . . . . . . "17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one"@en . . . . . . "Norethisteronum"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Mini-pill"@en . "19-Nor-ethindrone"@en . "(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one"@en . "17-alpha-Ethynyl-19-nortestosterone"@en . . "17alpha-Ethinylestra-4-en-17beta-ol-3-one"@en . "Micronor"@en . . . . "Norethindrone is 36% bound to sex hormone-binding globulin and 61% bound to albumin. "@en . . "68-22-4"@en . " * 0.4 L/hr/kg [plasma clearance] "@en . " "@en . . . . . . . . . . "Norcolut"@en . . . . "Norethindrone acetate is completely and rapidly deacetylated to norethindrone (NET) after oral administration, and the disposition of norethindrone acetate is indistinguishable from that of orally administered norethindrone. Norethindrone is rapidly absorbed from norethindrone acetate, in which maximum plasma concentration occur 2 hours post-dose (Tmax). When a single dose is given to healthy women, the Cmax is 26.19 \u00B1 6.19 hours. The AUC (0-inf) is 166.90 \u00B1 56.28 ng/mL*h. Absolute oral bioavailability is approximately 64%. The effect of food on the pharmacokinetics of norethindrone acetate is unknown. "@en . "17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one"@en . "Norethindrone"@en . . "17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one"@en . "Conludag"@en . . .